TrademarkDir
REMOXY
DEAD

Serial Number

86136868

Owner

KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.

Attorney

Megan K. Bowen

First Use Date

Mar 16, 2017

Filing Date

Dec 6, 2013

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

REMOXY Trademark

Serial Number: 86136868 • Registration: 5271468

REMOXY is a trademark filed by KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. on December 6, 2013. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. (69 trademarks)

501 FIFTH STREET
BRISTOL, TN 37920

Entity Type: 03

Pain Therapeutics, Inc. (13 trademarks)

2211 Bridgepointe Parkway
San Mateo, CA 94404

Entity Type: 03

Trademark Details

Filing Date

December 6, 2013

Registration Date

August 22, 2017

First Use Anywhere

March 16, 2017

First Use in Commerce

March 16, 2017

Published for Opposition

November 11, 2014

Cancellation Date

March 8, 2024

Filing History

CANCELLED SEC. 8 (6-YR)
Mar 8, 2024 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 22, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Aug 22, 2017 R.PR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 21, 2017 EXRA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 21, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 20, 2017 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jul 20, 2017 SUPC
SOU EXTENSION 5 GRANTED
Jul 20, 2017 EX5G
USE AMENDMENT FILED
Jul 5, 2017 IUAF
SOU EXTENSION 5 FILED
Jul 5, 2017 EXT5
SOU TEAS EXTENSION RECEIVED
Jul 5, 2017 EEXT
TEAS STATEMENT OF USE RECEIVED
Jul 5, 2017 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 13, 2017 EXRA
SOU EXTENSION 4 GRANTED
Jan 12, 2017 EX4G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 12, 2017 AITU
SOU EXTENSION 4 FILED
Jan 3, 2017 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 3, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 1, 2016 EXRA
SOU EXTENSION 3 GRANTED
Jun 30, 2016 EX3G
SOU EXTENSION 3 FILED
Jun 14, 2016 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 14, 2016 EEXT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 17, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 17, 2016 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Jan 22, 2016 EXRA
SOU EXTENSION 2 GRANTED
Jan 21, 2016 EX2G
SOU EXTENSION 2 FILED
Dec 22, 2015 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 22, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Jul 22, 2015 EXRA
SOU EXTENSION 1 GRANTED
Jul 21, 2015 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 15, 2015 AITU
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 24, 2015 ASGN
SOU EXTENSION 1 FILED
Jun 17, 2015 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 17, 2015 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jan 6, 2015 NOAM
PUBLISHED FOR OPPOSITION
Nov 11, 2014 PUBO
NOTICE OF PUBLICATION
Oct 22, 2014 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 7, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 30, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 24, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 24, 2014 CRFA
ASSIGNED TO LIE
Sep 16, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 12, 2014 TROA
NON-FINAL ACTION MAILED
Mar 21, 2014 CNRT
NON-FINAL ACTION WRITTEN
Mar 20, 2014 CNRT
ASSIGNED TO EXAMINER
Mar 18, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 18, 2013 NWOS
NEW APPLICATION ENTERED
Dec 10, 2013 NWAP

Related Trademarks

More from this Owner

FILORA

FILORA

FILORA

FILORA

FENROCK

FENROCK

FENROCK

FENROCK

OPTIMAL OPIOID PHARMACOTHERAPY IN INDIVIDUALIZED MULTIMODAL ANALGESIA logo

OPTIMAL OPIOID PHARMACOTHERAPY IN INDIVIDUALIZED MULTIMODAL ANALGESIA

OPTIMAL OPIOID PHARMACOTHERAPY IN INDIVIDUALIZED MULTIMODAL ANALGESIA logo

OPTIMAL OPIOID PHARMACOTHERAPY IN INDIVIDUALIZED MULTIMODAL ANALGESIA